Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06YUM
|
||||
| Former ID |
DIB011919
|
||||
| Drug Name |
AZD6423
|
||||
| Indication | Suicidal ideation [ICD10:R45.8] | Phase 1 | [1] | ||
| Company |
Astrazeneca
|
||||
| Target and Pathway | |||||
| Target(s) | NMDA receptor | Target Info | Antagonist | [2] | |
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT01926366) AZD6423 SAD/MAD Study in Healthy Volunteers. U.S. National Institutes of Health. | ||||
| REF 2 | Biology of the NMDA Receptor. Marie L. Blanke and Antonius M.J. VanDongen. 2009. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.